1540 studies found for:    Open Studies | "Virus Diseases"
Show Display Options
Rank Status Study
21 Recruiting GS-5806 in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Condition: Respiratory Syncytial Virus
Interventions: Drug: GS-5806;   Drug: Placebo
22 Unknown  Development of Method of Fructose Identification in Urine to Detect the Viral Infection
Condition: Human Immunodeficiency Virus
Intervention:
23 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment
Condition: Ebola Virus Disease
Intervention: Procedure: Convalescent Plasma Treatment
24 Not yet recruiting Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Condition: BK Virus Infection
Intervention: Biological: Viralym-B
25 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
26 Recruiting Identification of Viruses Associated With Diseases of Unknown Cause
Condition: Viral Diseases
Intervention:
27 Unknown  e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses
Conditions: Cervical Cancer;   Human Papilloma Virus Infection
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
28 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV cps2 Vaccine;   Biological: Placebo Vaccine
29 Not yet recruiting Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant
Conditions: Disorder Related to Renal Transplantation;   Immunosuppression Related Infectious Disease;   Virus Diseases
Interventions: Drug: mTOR inhibitor (everolimus);   Drug: cyclosporine or tacrolimus
30 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
31 Recruiting Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV MEDI ΔM2-2 vaccine;   Biological: Placebo vaccine
32 Unknown  Biliverdin Reductase A in Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Intervention:
33 Recruiting A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers
Conditions: Parainfluenza;   Respiratory Viral Infections
Intervention: Biological: Sendai virus vaccine
34 Recruiting Phase 1 Trial of Inactivated West Nile Virus Vaccine
Condition: West Nile Viral Infection
Interventions: Other: Placebo;   Biological: HydroVax-001
35 Recruiting A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Infection Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Infection
Condition: Acute Ebola Virus Infection
Intervention: Biological: INTERCEPT Plasma
36 Unknown  Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors
Condition: Chronic Hepatitis C Virus Infection
Intervention:
37 Recruiting A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.
Condition: Ebola Virus Disease
Intervention: Biological: Ad5-EBOV
38 Recruiting Clinical Trial of Efficacy of Anaferon for Children® in the Treatment of Influenza and Acute Respiratory Viral Infections in Children
Condition: Influenza and Acute Respiratory Viral Infections
Interventions: Drug: Anaferon for children;   Drug: Placebo
39 Unknown  Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatitis B Virus;   Recurrence
Interventions: Drug: antiviral treatment (lamivudine or entecavir);   Procedure: radical resection of HBV-related HCC
40 Recruiting Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection
Condition: Hepatitis C Virus
Interventions: Drug: Simeprevir 150 mg;   Drug: Daclatasvir 60 mg;   Drug: Sofosbuvir 400 mg

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years